July 20, 2005

SpeculatingStocks.com Stock Pick: American Oriental Bioengineering, Inc. (AOB)

Stock Price: $1.97 (long-term strong buy)

American Oriental Bioengineering, Inc. develops and produces bioengineered products and traditional Chinese medicinal products through its subsidiary, Harbin Bioengineering. At the end of last year, the company acquired a pharmaceutical company to enhance its product mix and categories offering. The newly acquired company focuses on medicinal products in the form of injection powder, pills, capsules and oral liquid.

AOB just received AMEX listing after listing on the bulletin board for much of its history. AOB can now experience the power of institutional investment and greater awareness. Already, AOB has received a "Strong Buy" investment rating from Westminster Securities placing a $4.05 six-month target on the firm.

On May 16th, the company reported record results of $9.65 million in revenue and net income of $2.18 million, or $0.05 per diluted share. Revenue for the same period last year was $5.91 million while net income was $1.26 million. On the balance sheet, cash and cash equivalents increased to $12.2 million while shareholders equity increased to $35.3 million -- both at their highest levels ever. The company deserves recognition for these feats, and if they continue their growth, AOB will only appreciate.

There are 43.6 million AOB fully diluted shares. Trading at a P/E of only 10, AOB will move higher.

SpeculatingStocks.com Target Price: We expect AOB to reach $4.00 within the next 3 months.